HSPA1A and glioblastoma: The application of these two assays to the analysis of a number of synthetic compounds resulted in the discovery of a negative regulator of Hsp70 activity that was found to sensitize melanoma and glioblastoma cells to the cytotoxic effect of doxorubicin.